Available online ---Key Words biliary atresia; bone health; bone mineral density; children; cytokines Background: Hepatic osteodystrophy is a common complication in patients with chronic liver disease, however, bone mineral status in patients with biliary atresia has rarely been investigated. Methods: Twenty-nine children with biliary atresia were enrolled in our study and their demographic data, bone mineral density (BMD) of lumbar spine and bilateral femoral neck, and biochemical parameters were measured and analyzed. Results: The majority of our patients had osteopenia or osteoporosis over at least one part of the skeleton although none had jaundice. Instead of T helper 1 cell cytokine, interleukin (IL)-4 had a significant negative correlation with BMD of the right femoral neck (b Z À0.251, p Z 0.027) and left femoral neck (b Z À0.299, p Z 0.012) independently by multiple linear regression analysis. Conclusion: We conclude that chronic inflammation with increased expression of IL-4 may be an important factor for compromised bone health in patients with biliary atresia.
Introduction
Biliary atresia is an infantile disorder of progressive inflammation and obliteration of both extrahepatic and intrahepatic bile ducts that leads to cirrhosis. 1 The pathogenesis of biliary atresia is thought to be an autoimmune response against the biliary epithelial cells after an unknown viral infection. The life expectancy of patients with biliary atresia has improved greatly due to early surgical intervention by Kasai portoenterostomy and subsequent liver transplantation. 2, 3 However, several complications developed in some of these patients, including osteopenia and osteoporosis, or so-called "hepatic osteodystrophy." 4 The mechanisms of bone disease in biliary atresia are not entirely understood. Chronic cholestasis, malabsorption of vitamin D and calcium, malnutrition, and decreased physical activity or sunlight exposure are possible factors contributing to bone loss in these patients. 5e7 However, compromised bone health was still identified in patients with biliary atresia even without these risk factors. 8 Previous studies have shown that CD4þ activated T helper (Th) cells, with different Th-cell cytokines playing an important role in the pathogenesis of biliary atresia. These include Th1 [interleukin (IL)-2, interferon gamma (IFN-g)], Th2 (IL-4, IL-10), Th3 [transforming growth factor (TGF)-b1], and Th17 (IL-17) cytokines. 9e12 These cytokines could also influence bone health in patients with chronic inflammatory disease according to previous reports. 13e16 Optimizing peak bone mass is of undoubted importance during childhood. 6 Nevertheless, data exploring the relationship between cytokines and bone health in children with biliary atresia are rare. In this article, we evaluated the demographic data, biochemical parameters, the concentrations of circulating cytokines, and bone mineral density (BMD) to analyze the determinants of bone health in children with biliary atresia.
Material and methods

Study population
Between August 2010 and August 2011, 29 biliary atresia patients (10 boys and 19 girls, age range 5e18 years) were recruited during routine follow up at our hospital. All patients had undergone a Kasai operation with shortduration (<6 months) steroid treatment following the surgery, and had no other chronic diseases. None of the patients received liver transplantation during enrollment. No fever or other acute illness was noted in any of our participants during blood sampling.
The study was approved by the institutional ethics committee of our hospital. All parents of children with biliary atresia and of the healthy controls were informed of the study's objectives. Informed consent from participating patients and/or parents was obtained before enrollment in the study, in accordance with the Helsinki Declaration.
Laboratory methods
Plasma was separated by centrifuging blood samples anticoagulated with EDTA at 3000g for 10 minutes. The plasma was stored at À70 C after an additional centrifugation at 13,000g for 10 minutes to ensure no contamination. We measured plasma IL-2, IL-4, IL-10, IL-17, IFN-g, and TGF-b1 concentrations using a commercially available enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN, USA). The concentrations were calculated from a standard curve according to the manufacturer's protocol. Plasma total bilirubin, direct bilirubin, aspartate aminotransferase (AST), alanine aminotransferase, gamma glutamyl transpeptidase, albumin, and calcium levels of biliary atresia patients were measured by the central laboratory using the Hitachi 7180 automated test system.
BMD measurements
BMD of biliary atresia patients was analyzed using dual energy X-ray absorptiometry (GE Lunar Prodigy Advance) over posterioreanterior lumbar spine (L1eL4) and bilateral femur neck areas. Control data were provided in the software of GE Lunar Prodigy Advance. BMD Z-scores in each part were obtained from comparisons of BMD with age-and ethnically-matched norms. Children were classified into normal, osteopenic, and osteoporotic by World Health Organization guidelines. Osteoporosis was defined as BMD ! 2.5 standard deviation (SD) below the average values (Z score À2.5). Osteopenia was defined as BMD < 2.5 SD but > 1 SD under the average values (À2.5 < Z score < À1.0). Normal BMD was defined as BMD 1 SD under the average values (Z score ! À1.0). BMD was expressed as g/cm 2 .
Statistical analyses
Results are expressed as mean AE SD. Analyses were performed using the statistical package for the social science (SPSS version 15.1; SPSS Inc., Chicago, IL, USA). The independent sample t test was employed for comparison of demographic and clinical data between groups. We applied the Pearson correlation test for correlation analysis and multiple linear regression analyses to investigate any relationships between BMD and other various independent parameters. A p value < 0.05 was considered statistically significant.
Results
BMD of the patients measured using dual energy X-ray absorptiometry is summarized in Table 1 . The majority of children with biliary atresia (20/29, 69%) were identified to have osteopenia over at least one part of the skeleton in this study. BMD Z-scores were within the osteopenic/ osteoporotic range in 6/1 (21/3%), 16/1 (55/3%), and 12/2 (41/7%) patients, respectively, over anterioreposterior lumbar spine (L1eL4), left femoral neck, and right femoral neck. Significant difference between genders was only found over BMD of the lumbar spine (p Z 0.010) but there was no difference between BMD Z-scores. The mean age-and ethnically-matched BMD Z-scores over three areas were all below average value, approaching the osteopenic range over the bilateral femoral neck (À0.53, e0.97, and À0.90).
Comparison of demographic data, biochemical parameters, and plasma cytokine levels between osteopenic and nonosteopenic biliary atresia patients at the weight-bearing skeleton is shown in Table 2 . All patients enrolled in the study were nonjaundiced. No significant difference was seen regarding age distribution, sex ratio, body height, body weight, biochemical parameters, or six plasma cytokine levels measured between the two groups.
Pearson correlation analyses for BMD are shown in Table  3 . BMD in patients with biliary atresia was highly correlated (p < 0.001) with age and body mass index in all three parts. There was also significant correlation (p Z 0.016 and 0.008, respectively) between circulating IL-4 level and bilateral femoral neck BMD.
We further performed multiple regression analyses with BMD as the dependent variable (Table 4 ). Age was identified to have a strongly positive correlation with lumbar and bilateral femoral neck BMD. Circulating IL-4 level was inversely correlated with left (b Z À0.299, p Z 0.012) and right (b Z À0.251, p Z 0.027) femoral neck BMD (Figures 1   and 2 ). There was no correlation between BMD and other parameters, including IFN-g level and body mass index.
Discussion
In this study, we described the relationship between different Th-cell cytokines and BMD in nonjaundiced patients with biliary atresia. It was proven that decreased BMD was a common complication in patients with biliary atresia, 17, 18 even when they were nonjaundiced. 8 Our findings indicate that circulating IL-4 level may be an Normal: BMD Z-score ! À1.0; osteopenia: À2.5 < BMD Z-score < À1.0; osteoporosis: BMD Z-score À2.5. BMD Z bone mineral density; SD Z standard deviation. independent factor for bone disease in patients with biliary atresia by multiple linear regression analysis. Biliary atresia is one of the most common causes of neonatal cholestasis. Patients with biliary atresia can achieve long-term survival in an era of successful Kasai portoenterostomy and liver transplantation. 19 Preventing complications, including hepatic osteodystrophy, has become the focus of care in these patients. Previous studies report that chronic cholestasis is a well-established risk factor for bone disease. 5, 20 Other mechanisms including malnutrition, malabsorption of minerals and fat-soluble vitamins, medication, or poor mobility were also discussed. 21 Due to the advancement in medical care, all patients in our study were free of jaundice, malnutrition, or hypocalcemia according to our data. Plasma 25hydroxyvitamin D level was determined in three of our patients and the results were all within the normal limit. However, decreased BMD was still found in the majority of our patients, especially over bilateral femoral neck areas.
The main pathogenesis of biliary atresia is believed to be a chronic inflammation caused by an uncontrollable autoimmune response. According to previous studies, various cytokines released by CD4þ Th cells may contribute to biliary atresia disease presentation and progression. 11, 12 We can divide CD4þ Th cells into four main subsets, including Th1, Th2, Th3, and Th17 cells. 22 Th1 cells activate macrophages by IFN-g and IL-2, while Th2 cells are responsible for humoral immune response by IL-4 and IL-10. Th3 cells produce immune modulating and suppressing cytokines such as TGF-b1. Th17 cells, a new effector CD4þ T cell lineage, were recently recognized. IL-17 is secreted by Th17 cells to recruit Th1 cells to the site of inflammation.
In a report by Narayanaswamy et al, 23 21 patients with biliary atresia showed a marked increase in the levels of Th1 (IFN-g and IL-2) and Th2 (IL-4) cytokines 6 months after the Kasai operation, compared with at the time of operation. According to our previous report, 12 increased IFN-g levels were found in jaundice-free biliary atresia patients with impaired liver function and portal hypertension. ASTto-platelet ratio index (APRI) is a simple tool used to assess the degree of liver fibrosis in children with biliary atresia following Kasai surgery. 24 IL-10 (Th2 cytokine) also increased in biliary atresia patients with high APRI values. 12 IFN-g and IL-10 are likely to be involved in progressive liver injury in patients with biliary atresia. These results indicated the progressive immune response of these patients was nonpolarized to Th1 or Th2 immunity. Bone disease is also found in other autoimmune or chronic inflammatory disorders, 25e27 therefore, it seems reasonable to consider that various CD4þ Th cell secreting cytokines may also cause osteopenia or osteoporosis in patients with biliary atresia. An interesting finding of our correlation analysis is that circulating IL-4 level, one of the Th2 cytokines, was significantly negatively correlated with BMD over bilateral femoral neck areas in patients with biliary atresia after adjusting for confounding factors. Although negative correlations between Th1, Th3, and Th17 cytokines and BMD were also observed, no significant difference was achieved. The mechanisms of liver injury and bone disease in patients with biliary atresia may be different.
Maintaining bone health is necessary for the balance between bone formation and resorption. In 1993, Lewis et al 28 reported that osteoporosis was induced in mice by the overproduction of IL-4 by the direction of the lymphocyte-specific proximal promoter for the lck gene. The results indicated that bone disease in lck-IL-4 mice appeared to result from decreased bone formation by marked atrophy of osteoblasts in lck-IL-4 bone tissue. Osteoporosis is also a common complication in immunodeficiency patients with hyper-IgE syndrome exposed to excess IL-4, 29 therefore it is plausible that circulating IL-4 can contribute to bone loss in patients with biliary atresia, although the precise mechanism is not known.
In conclusion, hepatic osteodystrophy is a common complication in patients with biliary atresia even if they are nonjaundiced. Optimizing peak bone mass is an important issue during the childhood and adolescent periods for these patients to prevent future complications in adulthood. Our data also provided further evidence that chronic inflammation with increased expression of IL-4 may be an independent factor for osteopenia or osteoporosis over bilateral femoral neck areas in patients with biliary atresia. Further larger prospective studies are necessary to investigate the mechanism of bone disease with various cytokines in order to prevent or treat bone mineral deficits in children with biliary atresia.
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